Values First Advisors Inc. Invests $43,000 in iShares Biotechnology ETF (NASDAQ:IBB)

Values First Advisors Inc. acquired a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 317 shares of the financial services provider’s stock, valued at approximately $43,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Glass Jacobson Investment Advisors llc lifted its position in iShares Biotechnology ETF by 150.6% during the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 122 shares during the period. PCA Investment Advisory Services Inc. acquired a new position in iShares Biotechnology ETF during the second quarter valued at $28,000. Horizon Bancorp Inc. IN acquired a new position in iShares Biotechnology ETF during the third quarter valued at $44,000. Massmutual Trust Co. FSB ADV lifted its position in iShares Biotechnology ETF by 164.2% during the fourth quarter. Massmutual Trust Co. FSB ADV now owns 362 shares of the financial services provider’s stock valued at $49,000 after purchasing an additional 225 shares during the period. Finally, CVA Family Office LLC acquired a new position in iShares Biotechnology ETF during the fourth quarter valued at $51,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 0.4 %

NASDAQ IBB traded down $0.57 on Thursday, reaching $137.22. 1,441,164 shares of the company’s stock traded hands, compared to its average volume of 1,868,127. iShares Biotechnology ETF has a fifty-two week low of $111.83 and a fifty-two week high of $141.16. The stock has a 50 day moving average price of $136.42 and a 200-day moving average price of $128.75.

iShares Biotechnology ETF Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were issued a $0.126 dividend. The ex-dividend date was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a yield of 0.37%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.